Thrombosis
News
FDA committee votes in favor of vorapaxar
Credit: Andre E.X.
News
Study reveals RBC function in clot contraction
Red blood cells (RBCs) take on a new shape and perform important functions in contracted blood clots, a new study suggests. Researchers found...
News
Chemo patients may have higher VTE risk than trials suggest
Credit: Andre E.X.
Clinical Review
Venous Thromboembolism
News
CDC finds cluster of newborns with late VKDB
The Centers for Disease Control and Prevention (CDC) has identified a small group of newborns in Tennessee with late vitamin K deficiency...
News
Factor can prevent bleeding in hemophilia A
Researchers found that prophylaxis with rFVIIIFc resulted in low annualized bleeding rates, and patients did not develop neutralizing antibodies...
News
New drug stacks up well against warfarin
AMSTERDAM—The oral anticoagulant edoxaban compares favorably with warfarin as treatment for recurrent venous thromboembolism (VTE), according to...
News
AMPLIFY: Apixaban beat warfarin on safety in acute VTE
Major finding: Major bleeds occurred in 0.6% of patients on apixaban and 1.8% of patients on warfarin, with similar efficacy. Data source: The...
News
Fraud, errors were behind delay of apixaban approval, report shows
Medication mistakes, reporting errors, and record changes are what led the US Food and Drug Administration (FDA) to delay approval of the...
News
Fusion protein controls surgery-related bleeding in hemophilia B
AMSTERDAM—A recombinant factor IX Fc fusion protein (rFIXFc) can control bleeding among hemophilia B patients undergoing major surgery, according...
News
New antiplatelet drug seems more effective than standard
SAN FRANCISCO—The novel antiplatelet agent cangrelor is more effective than clopidogrel as thromboprophylaxis for patients undergoing coronary...